Take our Survey on Innovative Medicines

Two years ago, PCNA engaged in a campaign to raise awareness about access to innovative cardiovascular medicines including PCSK9s, NOACs, and new heart failure therapies. We wish to know how this issue is currently impacting your practice and the lives of your patients.

We’ll be attending a stakeholder summit in Washington DC in March and will share the results of this survey with those in attendance.

Related Articles